Chemoinformaics analysis of Myricetin-3-O-Alpha-L-Arabinopyranoside
| Molecular Weight | 450.352 | nRot | 3 |
| Heavy Atom Molecular Weight | 432.208 | nRig | 24 |
| Exact Molecular Weight | 450.08 | nRing | 4 |
| Solubility: LogS | -3.949 | nHRing | 2 |
| Solubility: LogP | 0.055 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 55.0263 |
| nHD | 8 | BPOL | 24.1337 |
| QED | 0.244 |
| Synth | 4.072 |
| Natural Product Likeliness | 2.074 |
| NR-PPAR-gamma | 0.949 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.609 |
| HIA | 0.781 |
| CACO-2 | -6.299 |
| MDCK | 0.00000532 |
| BBB | 0.016 |
| PPB | 0.875711 |
| VDSS | 0.88 |
| FU | 0.155161 |
| CYP1A2-inh | 0.089 |
| CYP1A2-sub | 0.045 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.154 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.049 |
| CYP3a4-sub | 0.007 |
| CL | 4.257 |
| T12 | 0.89 |
| hERG | 0.033 |
| Ames | 0.728 |
| ROA | 0.039 |
| SkinSen | 0.812 |
| Carcinogencity | 0.031 |
| EI | 0.367 |
| Respiratory | 0.033 |
| NR-Aromatase | 0.855 |
| Antiviral | Yes |
| Prediction | 0.83252 |